Loading...

Novartis AG

NVS•NYSE
Healthcare
Drug Manufacturers - General
$145.47
$-2.01(-1.36%)
U.S. Market opens in 15h 23m

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap280.7B
P/E Ratio19.88
EPS (TTM)$7.15
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$151.91
3 Months$188.44
1 Year Target$163.60

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $163.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.88 and a market capitalization of 280.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.40%
5-Day Change
-4.04%
1-Month Change
-2.15%
3-Month Change
-1.17%
6-Month Change
11.55%
Year-to-Date (YTD) Change
5.48%
1-Year Change
30.81%
3-Year Change
52.77%
5-Year Change
75.02%
All-Time (Max) Change
824.48%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

75,883 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions